At a glance
ClinicalIndex Comparison RecordN/ACompleted· 110 enrolled
Drug / intervention
RIPC +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Biochemical and Reno-protective Effects of Remote Ischemic Pre-conditioning on Contrast-induced Acute Kidney Injury
In Brief
A clinical study evaluating RIPC and Sham-RIPC for Contrast-induced Acute Kidney Injury. Completed, enrolled 110 participants across 2 sites.
Detailed Summary
This a prospective, double-blind, sham-controlled, randomized clinical trial to study the effects of remote ischemic preconditioning on acute kidney injury, vascular and renal biomarkers in patients with non-ST elevation myocardial infarction and unstable angina undergoing coronary angiography and/or percutaneous coronary intervention.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsContrast-induced Acute Kidney Injury
CountriesUnited States
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedAug 2017
Enrollment StartMar 2018
Primary CompletionFeb 2023
Study CompletionFeb 2024
TodayJul 2026
First PostedAug 2, 2017
Enrollment StartMar 6, 2018
Primary CompletionFeb 28, 2023
Study CompletionFeb 28, 2024
TodayJul 2, 2026
Enrollment to primary: 5.0 yearsPosted 8.9 years ago
Interventions
RIPCdevice
Remote ischemic preconditioning
Sham-RIPCdevice
Control